跳至主要内容
临床试验/NCT03694691
NCT03694691招募中不适用

Development of a Liver Viability Index for Transplantation

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2018年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
60
试验地点
2
主要终点
Peak transaminase value post transplant

研究概览

简要总结

Machine perfusion technology is nearing the point of rescuing discarded liver grafts in the hope of proving them to be or improving them to the point of being transplantable. However, there are no validated metrics to determine transplantability after machine perfusion. This study involves collecting biopsies from transplanted livers before and after implantation to correlate metabolite and gene expression with post-transplant function. This data will help develop a viability index for machine perfused livers.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female 18-75 years of age.
  • Candidate for a deceased-donor liver allograft.

排除标准

  • Seropositivity for HIV-1.

结局指标

主要结局

Peak transaminase value post transplant

时间窗: 1 Year

The primary endpoint is peak transaminase values since transaminase elevation is a marker of hepatocyte injury

次要结局

  • Liver Graft Failure(1 Year)
  • Death(1 Year)
  • Kidney Failure(1 Year)
  • Acute Liver Rejection(1 Year)
  • Incidence of major Infection(1 Year)
  • Hepatitis C Recurrence (in Hepatitis C positive recipients)(1 Year)
  • Biliary Complications(1 Year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Heidi Yeh

Associate Professor

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验